Abstract:Objective The intestinal mucosal and immune barriers play considerable roles in the pathogenesis of necrotizing enterocolitis (NEC). The present research was designed to assess the protective effects of Lactobacillus reuteri (LR) DSM 17938 (LR 17938) on the intestinal barriers and its beneficial effects on inflammation in a neonatal mouse model of NEC. Study Design Overall, 7-day-old 75 C57BL/6 neonatal mice were separated into three groups ( n = 25) as follows: (1) control, (2) NEC, and (3) NEC + LR17938 (LR group). NEC mice were administered a hypertonic feeding formula and subjected to asphyxia and hypothermia. Hematoxylin and eosin (HE) staining and pathological scores were used to assess the pathological changes in the intestine. Oxidative stress was evaluated based on the levels of superoxide dismutase (SOD) and malondialdehyde (MDA). Tumor necrosis factor (TNF)-α and interleukin (IL)-1β levels were detected to assess inflammation. Gut permeability levels, bacterial translocation, and the levels of secretory idioglobulin A (sIgA), β-defensin, and tight junction (TJ) proteins were detected to evaluate gut mucosal and immune barrier function, and gut microbial diversity was detected to assess the composition of the gut flora. Results LR 17938 administration decreased the NEC-induced increase in intestinal scores, mortality rate, gut damage, the MDA level, and TNF-α and IL-1β expressions. Besides, LR 17938 improved the survival rate of NEC mice. Moreover, LR 17938 administration improved gut permeability levels, SOD activity and the bacterial translocation, ameliorated the expression of TJ proteins, and improved the gut microbiota compared with those of NEC mice. Conclusion LR 17938 reduced intestinal inflammation and played a protective role in a neonatal animal model of NEC, possibly by regulating oxidative stress and exerting a protective effect on the gut mucosal and immune barriers. Key Points Our research indicated a protective effect of LR 17938 on gut barrier function in NEC mice. LR 17938may affect the diversity of gut flora, which are known to target beneficial bacteria. LR 17938 protected gut barrier function in the NEC pups by improving gut permeability. The study protocol (CQMU20210813) was approved by the Experimental Animal Ethics Committee of Chongqing Medical University. Received: 15 April 2022 Accepted: 20 June 2022 Article published online: 11 November 2022 © 2022. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Type 3 immune response protects against Salmonella Typhimurium infection in the small intestine of neonatal rats

Protective Effects of Bifidobacteria on Intestines in Newborn Rats with Necrotizing Enterocolitis and Its Regulation on TLR2 and TLR4.

Suppression of IL-17 producing type 3 innate lymphoid cells and increased susceptibility to Klebsiella pneumoniae sepsis in neonatal mice exposed to extended empiric antibiotics

Bifidobacterium animalis subsp. lactis Boosts Neonatal Immunity: Unravelling Systemic Defences against Salmonella

Deleterious intestinal inflammation in neonatal mice treated with TLR2/TLR6 agonists

Oral Administration of Lactobacillus rhamnosus GG Ameliorates Salmonella Infantis-Induced Inflammation in a Pig Model via Activation of the IL-22BP/IL-22/STAT3 Pathway

Ontogeny of RORγt+ Cells in the Intestine of Newborns and Its Role in the Development of Experimental Necrotizing Enterocolitis.

Lactobacillusjohnsonii L531 Protects against Salmonella Infantis-Induced Intestinal Damage by Regulating the NOD Activation, Endoplasmic Reticulum Stress, and Autophagy

Time course of spontaneous bacterial translocation from gastrointestinal tract and its influential factors among neonatal rats

Bacterial Translocation in Neonatal Rats: The Relation Between Intestinal Flora, Translocated Bacteria, and Influence of Milk

Hyper Innate Responses In Neonates Lead To Increased Morbidity And Mortality After Infection

Hypersensitivity of Innate Response to Tlrs in Neonate

Gut microbiota-reactive IgG regulates gut microbiota development and immunity against enteric pathogens in early life

Protective Effects of Lactobacillus reuteri on Intestinal Barrier Function in a Mouse Model of Neonatal Necrotizing Enterocolitis

Lactobacillus johnsonii L531 Alleviates the Damage Caused by Salmonella Typhimurium via Inhibiting TLR4, NF-κB, and NLRP3 Inflammasome Signaling Pathways

Protective efficacy of a recombinant enterotoxin antigen in a maternal immunization model and the inhibition of specific maternal antibodies to neonatal oral vaccination

The formidable guardian: Type 3 immunity in the intestine of pigs

Induction of Innate Lymphoid Cell-Derived Interleukin-22 by the Transcription Factor STAT3 Mediates Protection Against Intestinal Infection.

Fetal Macrophages Exposed to Salmonella Antigens Elicit Protective Immunity Against Overwhelming Salmonella Challenge in A Murine Model

IL-36R signaling integrates innate and adaptive immune-mediated protection against enteropathogenic bacteria

TLR9 Limits Enteric Antimicrobial Responses and Promotes Microbiota Based Colonization Resistance during Citrobacter rodentium Infection.